Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 7:02 pm Sale |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 570,976 2.600% |
-868,403 (-60.33%) |
Filing History |
| 2023-01-27 6:01 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 1,439,379 6.900% |
1,439,379 (New Position) |
Filing History |
| 2022-02-11 4:19 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Ally Bridge MedAlpha Master Fund L.P. | 604,774 2.800% |
604,774 (New Position) |
Filing History |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% |
-121,000 (-7.46%) |
Filing History |
| 2022-02-11 4:17 pm Purchase |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 393,052 6.300% |
89,740 (+29.59%) |
Filing History |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,622,591 5.100% |
1,622,591 (New Position) |
Filing History |
| 2021-01-07 07:36 am Purchase |
2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Ally Bridge MedAlpha Master Fund L.P. | 929,979 9.990% |
929,979 (New Position) |
Filing History |
| 2020-12-18 4:20 pm Purchase |
2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 303,313 5.400% |
303,313 (New Position) |
Filing History |